Catatan efek · kuartal yang diarsipkan
MLTX
MoonLake Immunotherapeutics · Healthcare · Biotechnology
15Pemegang yang dilacak
+2Δ pemegang
5.30MSaham yang dipegang
$38.02MNilai yang dilaporkan
+3Posisi baru
−1Keluar
Input momentum (manajer yang sebanding):
keluasan pemegang +15.4% ·
aliran saham -30.0% ·
posisi baru bersih +13.3%
— formula
Fragmentasi kepemilikan — lebih banyak pemegang, agregat kepemilikan lebih kecil
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 59 | +3 | 21.61M | $421.37M | +4 | −1 |
| Q1 2026 | 59 | +5 | 21.19M | $393.03M | +8 | −3 |
| Q4 2025 | 55 | +1 | 18.04M | $237.83M | +3 | −2 |
| Q3 2025 | 15 | +2 | 5.30M | $38.02M | +3 | −1 |
| Q2 2025 | 10 | -1 | 11.33M | $534.65M | +1 | −2 |
| Q1 2025 | 8 | 0 | 5.66M | $221.05M | +2 | −2 |
| Q4 2024 | 8 | 0 | 7.28M | $394.17M | +1 | −1 |
| Q3 2024 | 7 | 0 | 7.26M | $366.27M | — | — |
| Q2 2024 | 7 | — | 8.40M | $369.30M | — | — |
Siapa yang memegangnya · Q3 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 1.50M | Baru | $10.76M | 0.0% | New | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 822.96K | -68.5% | $5.90M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 726.93K | -87.3% | $5.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 726.93K | -87.3% | $5.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 726.93K | -87.3% | $5.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 454.27K | Baru | $3.26M | 0.0% | New | 1 | SEC ↗ |
| 7 | Goldman Sachs Group ✦ | 362.87K | — | $2.60M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 348.32K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | JPMorgan Chase ✦ | 348.32K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | JPMorgan Chase ✦ | 348.32K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 348.32K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 348.32K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | JPMorgan Chase ✦ | 348.32K | — | $2.50M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 321.11K | -39.3% | $2.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | Marshall Wace ✦ | 321.11K | -39.3% | $2.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | Marshall Wace ✦ | 321.11K | -39.3% | $2.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 256.65K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 256.65K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 256.65K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 256.65K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 256.65K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 256.65K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (pasif) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | BlackRock ✦ (pasif) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | BlackRock ✦ (pasif) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | BlackRock ✦ (pasif) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 27 | BlackRock ✦ (pasif) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 28 | BlackRock ✦ (pasif) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | BlackRock ✦ (pasif) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | BlackRock ✦ (pasif) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | BlackRock ✦ (pasif) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | BlackRock ✦ (pasif) | 125.38K | -61.7% | $898,984 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 33 | The Vanguard Group ✦ (pasif) | 120.24K | -0.5% | $862,143 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 34 | The Vanguard Group ✦ (pasif) | 120.24K | -0.5% | $862,143 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 35 | The Vanguard Group ✦ (pasif) | 120.24K | -0.5% | $862,143 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 36 | The Vanguard Group ✦ (pasif) | 120.24K | -0.5% | $862,143 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | Millennium Management ✦ | 89.17K | Baru | $639,363 | 0.0% | New | 1 | SEC ↗ |
| 38 | Geode Capital Management ✦ (pasif) | 62.38K | +4.8% | $447,008 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 39 | State Street Global Advisors ✦ (pasif) | 52.89K | -18.1% | $379,193 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 40 | Citadel Advisors ✦ | 49.33K | -97.0% | $353,725 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 41 | Point72 Asset Management ✦ | 9.80K | -94.8% | $70,266 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Adage Capital Partners | $10.76M | 0.0% |
| Two Sigma Investments | $3.26M | 0.0% |
| Millennium Management | $639,363 | 0.0% |
Telah keluar
| Wellington Management | $1.01M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 145 pemegang, 61.96M saham, $1.12B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q3 2025 ·
Metodologi ·
Dapatkan ini melalui API